Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies11
  • 7D-2.8%
  • 3M3.9%
  • 1Y-50.2%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 2.0%, driven by a pullback from Nykode Therapeutics of 3.8%. In contrast, ArcticZymes Technologies has gained 5.4%. However, the industry is down 49% over the past year. As for the next few years, earnings are forecast to decline by 4.1% per annum.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024NOK 8.8bNOK 518.1m-NOK 1,057,386,592.6969.5x-8.3x17x
Sun, 23 Jun 2024NOK 8.9bNOK 641.0m-NOK 938,795,223.8336.6x-9.5x13.9x
Tue, 21 May 2024NOK 8.8bNOK 638.8m-NOK 978,127,299.4431.8x-9x13.7x
Thu, 18 Apr 2024NOK 8.3bNOK 660.5m-NOK 949,322,089.4637.1x-8.8x12.6x
Sat, 16 Mar 2024NOK 9.0bNOK 655.4m-NOK 935,914,720.5440.8x-9.6x13.7x
Mon, 12 Feb 2024NOK 15.2bNOK 672.2m-NOK 1,064,025,055.7441.6x-14.3x22.6x
Wed, 10 Jan 2024NOK 17.0bNOK 654.9m-NOK 1,354,587,829.0059.7x-12.5x25.9x
Fri, 08 Dec 2023NOK 15.0bNOK 662.6m-NOK 1,376,912,857.0056.7x-10.9x22.7x
Sun, 05 Nov 2023NOK 13.8bNOK 491.0m-NOK 1,549,505,083.0093x-8.9x28.1x
Tue, 03 Oct 2023NOK 15.3bNOK 626.0m-NOK 1,460,595,304.0055.4x-10.5x24.4x
Thu, 31 Aug 2023NOK 15.7bNOK 625.9m-NOK 1,430,493,766.0058.5x-11x25.1x
Sat, 29 Jul 2023NOK 16.3bNOK 555.1m-NOK 1,452,076,250.0058.2x-11.3x29.5x
Mon, 26 Jun 2023NOK 15.4bNOK 562.7m-NOK 1,483,024,567.0057.5x-10.4x27.4x
Wed, 24 May 2023NOK 17.3bNOK 562.8m-NOK 1,497,067,181.0064x-11.6x30.8x
Fri, 21 Apr 2023NOK 17.4bNOK 540.4m-NOK 1,450,451,254.0030.1x-12x32.2x
Sun, 19 Mar 2023NOK 15.0bNOK 538.6m-NOK 1,566,658,506.0029.5x-9.6x27.8x
Tue, 14 Feb 2023NOK 18.4bNOK 811.4m-NOK 1,413,475,376.0033.3x-13x22.7x
Thu, 12 Jan 2023NOK 18.1bNOK 812.7m-NOK 1,396,218,028.0025.5x-13x22.3x
Sat, 10 Dec 2022NOK 20.0bNOK 811.4m-NOK 1,395,546,113.0039.6x-14.3x24.6x
Mon, 07 Nov 2022NOK 17.4bNOK 805.0m-NOK 1,362,634,267.0036.1x-12.8x21.7x
Wed, 05 Oct 2022NOK 17.6bNOK 809.1m-NOK 1,363,217,532.0037.6x-12.9x21.7x
Fri, 02 Sep 2022NOK 20.5bNOK 795.0m-NOK 1,370,975,728.0036.8x-15x25.8x
Sun, 31 Jul 2022NOK 20.7bNOK 762.8m-NOK 1,379,134,362.0044.9x-15x27.2x
Tue, 28 Jun 2022NOK 19.9bNOK 765.8m-NOK 1,379,977,396.0043.2x-14.4x26x
Thu, 26 May 2022NOK 21.4bNOK 1.1b-NOK 1,032,317,067.0038x-20.8x19.7x
Sat, 23 Apr 2022NOK 25.5bNOK 1.0b-NOK 986,992,070.0041x-25.8x24.5x
Mon, 21 Mar 2022NOK 26.9bNOK 2.7bNOK 392.6m10.2x68.4x10.1x
Wed, 16 Feb 2022NOK 28.1bNOK 2.7bNOK 462.6m10.3x60.7x10.4x
Fri, 14 Jan 2022NOK 37.9bNOK 2.2bNOK 26.1m38.7x1453.4x17.6x
Sun, 12 Dec 2021NOK 39.1bNOK 2.2bNOK 68.1m41.8x574.1x17.6x
Tue, 09 Nov 2021NOK 36.8bNOK 2.6bNOK 462.8m14.4x79.5x14.4x
Thu, 07 Oct 2021NOK 37.5bNOK 2.6bNOK 483.0m14.9x77.7x14.6x
Sat, 04 Sep 2021NOK 39.8bNOK 2.6bNOK 508.1m17.5x78.3x15.5x
Mon, 02 Aug 2021NOK 35.7bNOK 2.6bNOK 508.1m14x70.4x13.9x
Price to Earnings Ratio

70.4x


Total Market Cap: NOK 35.7bTotal Earnings: NOK 508.1mTotal Revenue: NOK 2.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average 42.4x202220232024
Current Industry PE
  • Investors are pessimistic on the Norwegian Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 21.3x is higher than the industry's current PS ratio of 17.1x.
Past Earnings Growth
  • Total earnings for the Biotechnology industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 41% per year, which is driving profits down.

Industry Comparison

How does Norwegian Biotech compare with similar industries?

NO Market-1.27%
Healthcare-1.16%
Biotech-2.76%
Biotech-2.76%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ULTI UltimovacsNOK 7.903.9%
+NOK 10.3m		-89.8%PB1x
AZT ArcticZymes TechnologiesNOK 24.300.4%
+NOK 5.1m		-38.0%PE70.7x
LYTIX Lytix BiopharmaNOK 9.000.7%
+NOK 3.0m		32.4%PS30.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

EXTX

NOK 7.15

EXACT Therapeutics

7D

-10.1%

1Y

-37.8%

ABS

NOK 10.20

Arctic Bioscience

7D

-1.9%

1Y

-1.4%

NYKD

NOK 14.00

Nykode Therapeutics

7D

-3.9%

1Y

-52.3%

CRNA

NOK 2.16

Circio Holding

7D

-3.6%

1Y

-87.5%

ULTI

NOK 7.90

Ultimovacs

7D

3.9%

1Y

-89.8%

HBC

NOK 2.03

Hofseth BioCare

7D

-4.2%

1Y

-32.3%

BGBIO

NOK 12.85

BerGenBio

7D

-0.4%

1Y

18.8%

Companies Like BerGenBio (OB:BGBIO) Could Be Quite Risky

Jun 02
Companies Like BerGenBio (OB:BGBIO) Could Be Quite Risky

LYTIX

NOK 9.00

Lytix Biopharma

7D

0.7%

1Y

32.4%

AZT

NOK 24.30

ArcticZymes Technologies

7D

0.4%

1Y

-38.0%

TRMED

NOK 1.03

Thor Medical

7D

-0.8%

1Y

-43.1%

NANOV

NOK 2.00

Nordic Nanovector

7D

-18.3%

1Y

-22.2%